Inventor · disambiguated record
Elizabeth H. Kelley
Also filed as: KELLEY ELIZABETH H · KELLEY ELIZABETH HELEN
9 granted patents·3 pending applications·66 citations·filing 2010–2022
85Inventor score
Files withRELAY THERAPEUTICS INC7ASLANIAN ROBERT G1BOYCE CHRISTOPHER W1BROWN WILLIAM COLBY1GENENTECH INC1
Top patents by PatentIndex Score
12 records- 0196US10934302B1SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Mar 2, 2021·44 cites·7 claims
- 0291US12084447B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2020·Granted Sep 10, 2024·2 cites·20 claims
- 0385US11591336B2Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitorsRELAY THERAPEUTICS INC·Filed 2018·Granted Feb 28, 2023·3 cites·54 claims
- 0481US11629145B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2017·Granted Apr 18, 2023·3 cites·18 claims
- 0581US9023865B2Compounds that are ERK inhibitorsLIM JONGWON·Filed 2012·Granted May 5, 2015·4 cites·20 claims
- 0678US12331056B2SHP2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2022·Granted Jun 17, 2025·0 cites·21 claims
- 0778US8927559B2Quinazolinone-type compounds as CRTH2 antagonistsASLANIAN ROBERT G·Filed 2011·Granted Jan 6, 2015·6 cites·16 claims
- 0872US9469615B2Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Oct 18, 2016·4 cites·27 claims
- 0965US2022315586A1Shp2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1053US2024383915A1Oxazepine compounds and uses thereof in the treatment of cancerGENENTECH INC·Filed 2022·Application pending·0 cites
- 1149US2020392161A1Shp2 phosphatase inhibitors and methods of use thereofRELAY THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1230US8871796B2Diaryl ether derivatives as notch sparing gamma secretase inhibitorsBROWN WILLIAM COLBY·Filed 2010·Granted Oct 28, 2014·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →